That is the drugs intended future: obesity as an entry point, organ comorbidities as label-expansion targets
The injection is typically given in a muscle, most commonly in the upper arm, thigh, or buttock
His reduction in LV mass carries clinical significance as increased LV mass has been associated with a heightened risk for heart failure hospitalizations and cardiovascular death in heart failure with preserved ejection fraction [15]
Disclaimer The advice provided in this article is for informational purposes only
Wharton S, Lingvay I, Bogdansi P, et al
Looking ahead, employers may continue to face the competing pressures of employee demand for GLP-1 drugs and concerns about costs